Search

everythinglearnresearchcommunity

for

Search:↓

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Betamethasone oral mini-pulse therapy showed good or fair results in treating lichen planus.

Patients with oral lichen planus or oral lichenoid reactions had worse cholesterol levels and a higher risk of obesity compared to healthy individuals.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Tacrolimus solution is effective and well-tolerated for treating inflammatory scalp conditions.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Recognize and treat hair loss conditions that mimic androgenetic alopecia by identifying warning signs and using proper tools.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

A dog with unusual skin lesions near its tail was successfully treated for a rare form of lupus.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Stress may trigger hair loss by affecting immune protection in hair follicles.